Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized phase IV trial of switching from Triumeq to Genvoya for neuropsychiatric symptoms in adults with HIV
2016-004646-29Phase 4Completed
- Sponsor
- Fundación SEIMC-GeSIDA
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of abacavir, tenofovir alafenamide in human immunodeficiency virus infection (HIV), sponsored by Fundación SEIMC-GeSIDA. Started Apr 2017; status: completed.
02
Drugs
abacavirtenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2016-004646-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004646-29.